Exploring the effects of doxorubicin on survival rates in glioma patients: a comprehensive systematic review
Abstract Background Glioma is still one of the most aggressive and common types of brain and central nervous system cancer, with few effective treatment options. Despite progress in therapy, there is a requirement for new methods to enhance patient outcomes. Doxorubicin (DOX), a type of anthracyclin...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMC
2025-05-01
|
| Sarja: | European Journal of Medical Research |
| Aiheet: | |
| Linkit: | https://doi.org/10.1186/s40001-025-02674-5 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|